Oncolytic viruses and immune checkpoint inhibition: the best of both worlds V Sivanandam, CJ LaRocca, NG Chen, Y Fong, SG Warner Molecular Therapy-Oncolytics 13, 93-106, 2019 | 133 | 2019 |
The role of recombinant AAV in precise genome editing S Bijlani, KM Pang, V Sivanandam, A Singh, S Chatterjee Frontiers in Genome Editing 3, 799722, 2022 | 36 | 2022 |
Oncolytic poxvirus CF33-hNIS-ΔF14. 5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model S Chaurasiya, A Yang, S Kang, J Lu, SI Kim, AK Park, V Sivanandam, ... Oncoimmunology 9 (1), 1729300, 2020 | 34 | 2020 |
A novel chimeric poxvirus encoding hNIS is tumor-tropic, imageable, and synergistic with radioiodine to sustain colon cancer regression SG Warner, SI Kim, S Chaurasiya, MP O’Leary, J Lu, V Sivanandam, ... Molecular Therapy-Oncolytics 13, 82-92, 2019 | 34 | 2019 |
Recombinant orthopoxvirus primes colon cancer for checkpoint inhibitor and cross-primes T cells for antitumor and antiviral immunity SI Kim, AK Park, S Chaurasiya, S Kang, J Lu, A Yang, V Sivanandam, ... Molecular cancer therapeutics 20 (1), 173-182, 2021 | 23 | 2021 |
Functional analysis of the N-terminal basic motif of a eukaryotic satellite RNA virus capsid protein in replication and packaging V Sivanandam, D Mathews, R Garmann, G Erdemci-Tandogan, R Zandi, ... Scientific reports 6 (1), 26328, 2016 | 20 | 2016 |
Adeno-associated virus and hematopoietic stem cells: the potential of adeno-associated virus hematopoietic stem cells in genetic medicines S Chatterjee, V Sivanandam, KKM Wong Human Gene Therapy 31 (9-10), 542-552, 2020 | 7 | 2020 |
Properties of satellite tobacco mosaic virus phenotypes expressed in the presence and absence of helper virus V Sivanandam, D Mathews, ALN Rao Virology 483, 163-173, 2015 | 7 | 2015 |
Regulation of Positive-Strand Accumulation by Capsid Protein During Brome mosaic virus Infection In Planta M de Wispelaere, V Sivanandam, ALN Rao Phytopathology 110 (1), 228-236, 2020 | 6 | 2020 |
Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancer SI Kim, S Chaurasiya, V Sivanandam, S Kang, AK Park, J Lu, A Yang, ... Molecular Therapy-Oncolytics 24, 864-872, 2022 | 3 | 2022 |
Heterologous replicase driven 3′ end repair of Cucumber mosaic virus satellite RNA V Sivanandam, E Varady, ALN Rao Virology 478, 18-26, 2015 | 1 | 2015 |
Deciphering the Mechanism of Nuclease- Free Homologous Recombination Based Genome Editing LV Bugga, V Sivanandam, E Rodriguez, KM Pang, S Chatterjee Molecular Therapy 31 (4S1, April 2023), 762, 2023 | | 2023 |
Unraveling the Mechanism of Precise AAV-based Genome Editing V Sivanandam, JPG Dahua, KM Pang, S Chatterjee The American Society of Gene & Cell Therapy 30 (Molecular Therapy), 92-93, 2022 | | 2022 |
A Universal High Density Cell Respirator (HDCR) Bioreactor for Intensified Production of Gene Therapy Vectors CA Cook, C Boyoglu, L Bugga, YH Liu, J Lu, KM Pang, V Sivanandam, ... Molecular Therapy 28 (4), 30-31, 2020 | | 2020 |
Virus-Host Cell Protein-Protein Interactions of Filovirus VP40 V Sivanandam, VJ Heintz, O Shtanko, RA Davey, DJ LaCount The American Society for Virology, Annual Meeting, 326, 2017 | | 2017 |